Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.

导出 OA

翻译打印收藏纠错

第一作者： Keying,Che

第一单位： Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

作者： Keying,Che ^[1] ; Yuting,Luo ^[2] ; Xueru,Song ^[3] ; Zhe,Yang ^[1] ; Hanbing,Wang ^[1] ; Tao,Shi ^[3] ; Yue,Wang ^[1] ; Xuan,Wang ^[1] ; Hongyan,Wu ^[1] ; Lixia,Yu ^[1] ; Baorui,Liu ^[4] ; Jia,Wei ^[5]

作者单位： Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. ^[1] State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. ^[2] Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. ^[3] Department of Pathology, The Third Affiliated Hospital of Soochow University, Changzhou, China. ^[4] Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. ^[5] Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. jiawei99@nju.edu.cn. ^[6] State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. jiawei99@nju.edu.cn. ^[7] Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, China. jiawei99@nju.edu.cn. ^[8] Engineering Research Center of Protein and Peptide Medicine, Ministry of Education, Nanjing, China. jiawei99@nju.edu.cn. ^[9]

关键词 Gastric Cancer IL-33 Peritoneal Metastasis Tumor Immune Microenvironment Tumor-associated Macrophages